There are now eight states that have filed a class action lawsuit against Eli Lilly, the maker of the drug Zyprexa. The lawsuits have been filed because Eli Lilly allegedly advertised the drug for uses that were not approved by the FDA. They also claim that the drug manufacturer did not properly warn of potential side effects.
A representative from Myers’ office confirmed Tuesday that Oregon “is part of the leadership states (Executive Committee) for a multi-state case concerning Eli Lilly and Zyprexa”, Dawdy reported. Myers would use in-house staff rather than private lawyers as Montana recently did, the official added.
Just over two years ago, Indianapolis-based Eli Lilly announced it had paid around $690 million to settle claims, including class-action lawsuits, over claims it minimized Zyprexa’s side-effects. But Lilly also warned it would fight other legal claims against Zyprexa.
The states claim the price of Zyprexa was artificially inflated by the company so their Medicare and Medicaid programs had to pay out higher claims.
For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.